Show simple item record

dc.contributor.authorBryant, JE
dc.contributor.authorAzman, AS
dc.contributor.authorFerrari, MJ
dc.contributor.authorArnold, BF
dc.contributor.authorBoni, MF
dc.contributor.authorBoum, Y
dc.contributor.authorHayford, K
dc.contributor.authorLuquero, FJ
dc.contributor.authorMina, MJ
dc.contributor.authorRodriguez-Barraquer, I
dc.contributor.authorWu, JT
dc.contributor.authorWade, D
dc.contributor.authorVernet, G
dc.contributor.authorLeung, DT
dc.date.accessioned2020-07-09T22:05:32Z
dc.date.available2020-07-09T22:05:32Z
dc.date.issued2020-05-19
dc.date.submitted2020-07-09
dc.identifier.pmid32430309
dc.identifier.doi10.1126/sciimmunol.abc6347
dc.identifier.urihttp://hdl.handle.net/10144/619667
dc.description.abstractSerological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).en_US
dc.language.isoenen_US
dc.publisherAmerican Association for the Advancement of Scienceen_US
dc.rightsWith thanks to American Association for the Advancement of Science.en_US
dc.titleSerology for SARS-CoV-2: Apprehensions, opportunities, and the path forwarden_US
dc.typeArticle
dc.typeOther
dc.identifier.eissn2470-9468
dc.identifier.journalScience Immunologyen_US
dc.source.journaltitleScience immunology
dc.source.volume5
dc.source.issue47
refterms.dateFOA2020-07-09T22:05:33Z
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
Bryant et al 2020 Serology for ...
Size:
1.223Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record